Real-time enrollment status for this sars-cov infection clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 2:39 PM UTC
| NCT Number | NCT05886816 |
| Recruiting Status | Recruiting |
| Condition | SARS-CoV Infection |
| Phase | PHASE2 |
| Target Enrollment | 112 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Texas Southwestern Medical Center |
| Last Updated on CT.gov | March 16, 2026 (Mar 16, 2026) |
As of August 31, 2026: Clinical trial NCT05886816 is currently recruiting participants. This phase2 study for sars-cov infection is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Texas Southwestern Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05886816 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05886816 was last updated Mar 16, 2026 (March 16, 2026). HelloStudys verifies this status automatically.